abiraterone has been researched along with axitinib in 1 studies
| Studies (abiraterone) | Trials (abiraterone) | Recent Studies (post-2010) (abiraterone) | Studies (axitinib) | Trials (axitinib) | Recent Studies (post-2010) (axitinib) |
|---|---|---|---|---|---|
| 942 | 97 | 854 | 765 | 145 | 683 |
| Protein | Taxonomy | abiraterone (IC50) | axitinib (IC50) |
|---|---|---|---|
| Serine/threonine-protein kinase PLK4 | Homo sapiens (human) | 0.045 | |
| Tyrosine-protein kinase ABL1 | Homo sapiens (human) | 0.0658 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.046 | |
| Vascular endothelial growth factor receptor 1 | Homo sapiens (human) | 0.0001 | |
| Vascular endothelial growth factor receptor 3 | Homo sapiens (human) | 0.0001 | |
| Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.0079 | |
| Serine/threonine-protein kinase TBK1 | Homo sapiens (human) | 0.47 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goozner, M | 1 |
1 other study(ies) available for abiraterone and axitinib
| Article | Year |
|---|---|
Drug approvals 2011: focus on companion diagnostics.
Topics: Androstenes; Androstenols; Antibodies, Monoclonal; Antineoplastic Agents; Axitinib; Biomarkers, Tumor; Brentuximab Vedotin; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Crizotinib; Drug Approval; Female; Humans; Imidazoles; Immunoconjugates; Indazoles; Indoles; Ipilimumab; Lung Neoplasms; Male; Melanoma; Molecular Targeted Therapy; Neoplasms; Piperidines; Prostatic Neoplasms; Pyrazoles; Pyridines; Quinazolines; Rare Diseases; Sulfonamides; Survival Analysis; United States; United States Food and Drug Administration; Vemurafenib | 2012 |